|
⚲
|
| Keyboard |
| MGF Partners II LP - TCV Global Growth XIII Series | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0002157169 |
| Sale | 2026-09-23 (4.1 M Offered, 4.1 M Sold) |
| Fund | Other Private Fund |
| Phone | 7818481163 |
| Address | 30 Braintree Hill Office Park Braintree, MA 02184 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Form D Offering | |
|---|---|
| Filed | 2026-09-29 (D) |
| Exemption | 506(b), 3(c), 3(c)(7) |
| Duration | One year or less |
| Net Assets | Decline to Disclose |
| Directors | Role | 2011 - 2026 |
|---|---|---|
| Mary Gilligan | Executive Officer | |
| MGF II LLC | Executive Officer |
| Comparable Firms | State | AUM |
|---|---|---|
|
Advancit Capital Advisors LLC
✚
|
MA | |
|
Putnam Investments LLC
✚
|
MA | |
|
Choate Investment Advisors
✚
|
MA | |
|
GRT Capital Partners LLC
✚
|
MA | |
|
TRV GP IV LLC
✚
|
MA | |
|
Wellington Management Co LLP
✚
|
MA | |
|
Bain Capital Life Sciences Investors LLC
✚
|
MA | |
|
Berylson Capital Partners LLC
✚
|
MA | |
|
Tepper Robert I
✚
|
MA | |
|
Bogle Investment Management L P
✚
|
MA |